DTCA
This page lists 293 references in the Main Healthy Skepticism Library relevant to Direct To Consumer Advertising of prescription drugs.
Click on the HSL (Health Skepticism Library) number for more details which may include an abstract or full text.
HSL6927
Cassels A.
Cholesterol TV ads clog reality
Common Ground Magazine 2006 Nov 1
HSL6709
Canadian Health Services Research Foundation.
Direct-to-consumer advertising is educational for patients.
J Health Serv Res Policy 2006 Jul 01;11(3):189-90
Link to source with long URL
HSL5809
Cassels A.
Canada may be forced to allow direct to consumer advertising.
BMJ 2006 Jun 24;332(7556):1469
http://bmj.bmjjournals.com/cgi/content/full/332/7556/1469-a
HSL5821
Kravitz RL, Halpern J.
Direct-to-consumer drug ads, patient autonomy and the responsible exercise of power
Virtual Mentor: Ethics Journal of the American Medical Association 2006 Jun 1;8(6):407-411
http://www.ama-assn.org/ama/pub/category/16259.html
HSL6391
Mahon SM.
Impact of direct-to-consumer advertising on healthcare providers and consumers.
Clin J Oncol Nurs 2006 Jun 01;10(3):417-20
HSL5617
Kondro W.
Eliminating barriers to DTC advertising for OTCs and natural health products.
CMAJ 2006 May 23;174(11):1547-8
http://www.cmaj.ca/cgi/content/full/174/11/1547
HSL4381
Almasi E, Stafford R, Kravitz RL, Mansfield PR.
What Are the Public Health Effects of Direct-to-Consumer Drug Advertising?
PLoS Medicine 2006 Mar 28;3(3):e145
Link to source with long URL
HSL5751
Mack J.
Counterpoint: biotech needs more than DTC as usual.
Nat Biotechnol 2006 Mar 01;24(3):267
http://www.nature.com/nbt/journal/v24/n3/full/nbt0306-267.html
HSL6647
Felsenfeld AL.
How sweet it isn't.
J Calif Dent Assoc 2006 Mar 01;34(3):193-4
HSL5302
Brekke KR, Kuhn M.
Direct to consumer advertising in pharmaceutical markets.
J Health Econ 2006 Jan;25(1):102-30
Link to source with long URL
HSL5398
Hasman A, Holm S.
Direct-to-consumer advertising: should there be a free market in healthcare information?
Camb Q Healthc Ethics 2006 Win;15(1):42-9
HSL6103
Wakefield M, Durrant R.
Effects of exposure of youths at risk for smoking to television advertising for nicotine replacement therapy and Zyban: an experimental study.
Health Commun 2006;19(3):253-8
http://www.leaonline.com/doi/abs/10.1207/s15327027hc1903_7
HSL6499
Vuorenkoski L.
[The case of rofecoxib(Vioxx)-what do we learn from this case].
Duodecim 2006;122(4):385-6
HSL6570
Datti B, Carter MW.
The effect of direct-to-consumer advertising on prescription drug use by older adults.
Drugs Aging 2006;23(1):71-81
HSL6644
Bradford WD, Kleit AN, Nietert PJ, Steyer T, McIlwain T, Ornstein S.
How Direct-To-Consumer Television Advertising For Osteoarthritis Drugs Affects Physicians' Prescribing Behavior.
Health Aff 2006 Sep-Oct;25(5):1371-1377
http://content.healthaffairs.org/cgi/content/full/25/5/1371
HSL5367
Feinberg DT.
'Daddy, what is erectile dysfunction?' Direct-to-consumer advertising will be changing.
J Child Adolesc Psychopharmacol 2005 Dec;15(6):866-8
Link to source with long URL
HSL5044
Mintzes B, Morgan S, Bassett KL.
Medicine by media: did a critical television documentary affect the prescribing of cyproterone--estradiol (Diane-35)?
CMAJ 2005 Nov 22;173(11):1313-5
http://www.cmaj.ca/cgi/content/full/173/11/1313
HSL5607
Lacasse JR, Leo J.
Serotonin and depression: a disconnect between the advertisements and the scientific literature.
PLoS Med 2005 Dec;2(12):e392
Link to source with long URL
HSL5050
Kaphingst KA, Rudd RE, Dejong W, Daltroy LH.
Comprehension of information in three direct-to-consumer television prescription drug advertisements among adults with limited literacy.
J Health Commun 2005 Oct-Nov;10(7):609-19
Link to source with long URL
HSL5057
Mouchawar J, Laurion S, Ritzwoller DP, Ellis J, Kulchak-Rahm A, Hensley-Alford S.
Assessing controversial direct-to-consumer advertising for hereditary breast cancer testing: reactions from women and their physicians in a managed care organization.
Am J Manag Care 2005 Oct;11(10):601-8
http://www.ajmc.com/Article.cfm?ID=2955&CFID=3768231&CFTOKEN=45537093
HSL2732
Sharfstein SS.
Big Pharma and American Psychiatry: The Good, the Bad, and the Ugly.
Psychiatric News 2005 Aug 19;40(16):3
http://pn.psychiatryonline.org/cgi/content/full/40/16/3
HSL2673
Roner L
Moving beyond DTC
eyeforpharma Briefing 2005 Aug 17(151)
http://www.eyeforpharma.com/index.asp?nli=o&g-p&nld=8/17/2005&news=47333
HSL4177
Miller FG, Wendler D.
Direct-to-consumer advertising and physician prescribing.
JAMA 2005 Aug 10;294(6):678
http://jama.ama-assn.org/cgi/content/full/294/6/678
HSL4055
New DTC guidelines please drug companies, anger critics.
Med Health 2005 Aug 8;59(27):5-6
HSL2686
Gilbody S, Wilson P, Watt I.
Benefits and harms of direct to consumer advertising: a systematic review.
Qual Saf Health Care ( BMJ Journals) 2005 Aug;14(4):246-50
http://qhc.bmjjournals.com/cgi/content/full/14/4/246
HSL6412
Toop L, Richards D, Dowell T.
Response to Maubach and Hoek's paper on GP attitudes to DTCA
N Z Med J. 2005 Jun 24;118(1217):U1543
HSL4047
Direct-to-consumer advertising: impact on prescribing.
Child Health Alert 2005 Jun;24:5-6
Link to source with long URL
HSL6663
Mbongue TB, Sommet A, Pathak A, Montastruc JL.
'Medicamentation' of society, non-diseases and non-medications: a point of view from social pharmacology.
Eur J Clin Pharmacol 2005 Jun 01;61(4):309-13
http://www.springerlink.com/content/t212237555u30773/
HSL3797
Larson RJ, Schwartz LM, Woloshin S, Welch HG.
Advertising by academic medical centers.
Arch Intern Med 2005 Mar 28;165(6):645-51
Link to source with long URL
HSL6578
Schommer JC.
Direct-to-Consumer advertising for prescription drugs.
Minn Med 2005 Mar 01;88(3):32-3,
HSL4171
Graham DJ, Campen D, Hui R, Spence M, Cheetham C, Levy G, Shoor S, Ray WA.
Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study.
Lancet 2005 Feb 5-11;365(9458):475-81
http://linkinghub.elsevier.com/retrieve/pii/S0140673605178647
HSL4142
Berndt ER.
To inform or persuade? Direct-to-consumer advertising of prescription drugs.
N Engl J Med 2005 Jan 27;352(4):325-8
Link to source with long URL
HSL2383
Mansfield PR, Mintzes B, Richards D, Toop L.
Direct to consumer advertising.
BMJ 2005 Jan 1;330(7481):5-6
http://bmj.bmjjournals.com/cgi/content/full/330/7481/5
HSL5670
Lacasse JR.
Consumer advertising of psychiatric medications biases the public against nonpharmacological treatment.
Ethical Hum Psychol Psychiatry 2005 Fal 01;7(3):175-9
HSL4188
Chin MH.
The patient's role in choice of medications: direct-to-consumer advertising and patient decision aids.
Yale J Health Policy Law Ethics 2005 Sum;5(2):771-84
HSL5294
Chandra A, Miller M.
A closer look at the concept, historical overview, and value of direct-to-consumer advertising of prescription drugs.
Hosp Top 2005 Fall;83(4):32-6
HSL5514
Lau Y.
Is banning direct to consumer advertising of prescription medicine justified paternalism?
J Bioeth Inq 2005;2(2):69-74
HSL6298
Curry TJ, Jarosch J, Pacholok , S.
Are Direct to Consumer Advertisements of Prescription Drugs Educational?: Comparing 1992 to 2002.
Journal of Drug Education 2005;35(3):217-232
HSL1925
Waack KE, Ernst ME, Graber MA.
Informational content of official pharmaceutical industry web sites about treatments for erectile dysfunction.
Ann Pharmacother 2004 Dec;38(12):2029-34
http://www.theannals.com/cgi/content/full/38/12/2029
HSL1926
Donohue JM, Berndt ER, Rosenthal M, Epstein AM, Frank RG.
Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression.
Med Care 2004 Dec;42(12):1176-85
Link to source with long URL
HSL2081
Brownfield ED, Bernhardt JM, Phan JL, Williams MV, Parker RM.
Direct-to-consumer drug advertisements on network television: an exploration of quantity, frequency, and placement.
J Health Commun 2004 Nov-Dec;9(6):491-7
Link to source with long URL
HSL4138
Topol EJ.
Failing the public health--rofecoxib, Merck, and the FDA.
N Engl J Med 2004 Oct 21;351(17):1707-9
http://content.nejm.org/cgi/content/extract/351/17/1707
HSL2821
Donohue JM, Berndt ER.
Effects of Direct-to-Consumer Advertising on Medication Choice: The Case of Antidepressants
Journal of Public Policy & Marketing 2004 Fall;23(2):115–127
Link to source with long URL
HSL2076
Centers for Disease Control and Prevention (CDC).
Genetic testing for breast and ovarian cancer susceptibility: evaluating direct-to-consumer marketing--Atlanta, Denver, Raleigh-Durham, and Seattle, 2003.
MMWR Morb Mortal Wkly Rep 2004 Jul 16;53(27):603-6
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5327a1.htm
HSL2820
Frankenberger KA, Frankenberger WR, Peden BF, Hunt HL, Raschick CM, Steller EG, Peterson JA.
Effects of information on college students' perceptions of antidepressant medication.
J Am Coll Health 2004 Jul-Aug;53(1):35-40
HSL1358
Toop L, Richards D.
Physicians' negative views of direct-to-consumer advertising (DTCA): the international evidence grows.
N Z Med J 2004 Jun 4;117(1195):U905
HSL1360
Toivianen H, Vuorenkoski L, Hemminki E.
Finnish physicians show little support for consumer advertising of prescription drugs.
N Z Med J 2004 Jun 4;117(1195):U907
HSL2809
Fabius AM, Cheung KC, Rijcken CJ, Vinkers CH, Talsma H.
Direct-to-consumer communication on prescription only medicines via the internet in the Netherlands, a pilot study. Opinion of the pharmaceutical industry, patient associations and support groups.
Pharm World Sci. 2004 Jun;26(3):169-72. 2004 Jun 01;26(3):169-72
Link to source with long URL
HSL2079
Caudill-Slosberg MA, Schwartz LM, Woloshin S.
Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs 2000.
Pain 2004 Jun;109(3):514-9
http://linkinghub.elsevier.com/retrieve/pii/S0304395904001307
HSL239
Burton B.
Drug industry to fight New Zealand's move to ban direct to consumer advertising.
BMJ 2004 May 1;328(7447):1036
http://bmj.bmjjournals.com/cgi/content/full/328/7447/1036-d
HSL285
Robinson AR, Hohmann KB, Rifkin JI, Topp D, Gilroy CM, Pickard JA, Anderson RJ.
Direct-to-consumer pharmaceutical advertising: physician and public opinion and potential effects on the physician-patient relationship.
Arch Intern Med 2004 Feb 23;164(4):427-32
http://archinte.ama-assn.org/cgi/content/full/164/4/427
HSL4170
Burton B.
New Zealand moves to ban direct advertising of drugs.
BMJ 2004 Jan 10;328(7431):68
http://bmj.bmjjournals.com/cgi/content/full/328/7431/68-c
HSL1340
Woloshin S, Schwartz LM, Welch HG.
The value of benefit data in direct-to-consumer drug ads.
Health Aff (Millwood) 2004 Jan-Jun;Suppl Web Exclusives:W4-234-45
http://content.healthaffairs.org/cgi/reprint/hlthaff.w4.234v1
HSL304
Murray E, Lo B, Pollack L, Donelan K, Lee K.
Direct-to-consumer advertising: public perceptions of its effects on health behaviors, health care, and the doctor-patient relationship.
J Am Board Fam Pract 2004 Jan;17(1):6-18
http://www.jabfp.org/cgi/content/full/17/1/6
HSL1344
Weissman JS, Blumenthal D, Silk AJ, Newman M, Zapert K, Leitman R, Feibelmann S.
Physicians report on patient encounters involving direct-to-consumer advertising.
Health Aff (Millwood) 2004 Jan-Jun;Supplment Web Exclus:W4-219-33
http://content.healthaffairs.org/cgi/reprint/hlthaff.w4.219v1
HSL1349
Waxman HA.
Ensuring that consumers receive appropriate information from drug ads: what is the FDA's role?
Health Aff (Millwood) 2004 Jan-Jun;Supplment Web Exclus:W4-256-8
http://content.healthaffairs.org/cgi/reprint/hlthaff.w4.256v1
HSL1366
Sumpradit N, Ascione FJ, Bagozzi RP.
A cross-media content analysis of motivational themes in direct-to-consumer prescription drug advertising.
Clin Ther 2004 Jan;26(1):135-54
Link to source with long URL
HSL2788
Jeffords JM.
Direct-to-consumer drug advertising: you get what you pay for.
Health Aff (Millwood) 2004 Jan-Jun;Suppl
http://content.healthaffairs.org/cgi/reprint/hlthaff.w4.253v1
HSL2789
Kelly P.
DTC advertising's benefits far outweigh its imperfections.
Health Aff (Millwood) 2004 Jan-Jun;Suppl
http://content.healthaffairs.org/cgi/reprint/hlthaff.w4.246v1
HSL2790
Pitts , P. J.
Turning point or tipping point: new FDA draft guidances and the future of DTC advertising
Health Aff 2004 Jan;Suppl Web Exclusives:W4-259-61
HSL2793
Riggs DL, Holdsworth SM, McAvoy DR.
Direct-to-consumer advertising: developing evidence-based policy to improve retention and comprehension.
Health Aff (Millwood) 2004 Jan-Jun;Suppl
http://content.healthaffairs.org/cgi/reprint/hlthaff.w4.249v1
HSL1342
Welch Cline RJ, Young HN.
Marketing drugs, marketing health care relationships: a content analysis of visual cues in direct-to-consumer prescription drug advertising.
Health Commun 2004;16(2):131-57
HSL2211
Huh J, DeLorme DE, Reid LN.
Media credibility and informativeness of direct-to-consumer prescription drug advertising.
Health Mark Q 2004;21(3):27-61
HSL6416
Toop L.
Last time around for DTCA
N Z Med J. 2003 Nov 21;116(1186):U693
HSL2241
Millstein LG.
Prescription drug advertising: is it a driving force on drug pricing?
N C Med J 2003 Nov-Dec;64(6):289-91
HSL2232
Peebles ME.
And now, a word from our sponsor.
Harv Bus Rev 2003 Oct;81(10):31-5
HSL2237
Morgan S, Mintzes B, Barer M.
The economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare?
J Health Serv Res Policy 2003 Oct;8(4):237-44
Link to source with long URL
HSL415
Mansfield PR, Mintzes B.
Direct-to-consumer advertising is more profitable if it is misleading.
N Z Med J 2003 Sep 26;116(1182):U610
http://www.nzma.org.nz/journal/116-1182/610/
HSL2240
Mintzes B, Barer ML, Kravitz RL, Bassett K, Lexchin J, Kazanjian A, Evans RG, Pan R, Marion SA.
How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA
CMAJ. 2003 Sep 2;169(5):405-12
http://www.cmaj.ca/cgi/content/full/169/5/405
HSL4154
Gardner DM, Mintzes B, Ostry A.
Direct-to-consumer prescription drug advertising in Canada: permission by default?
CMAJ 2003 Sep 2;169(5):425-7
Link to source with long URL
HSL4146
Quick JD, Hogerzeil HV, Rago L, Reggi V, de Joncheere K.
Ensuring ethical drug promotion--whose responsibility?
Lancet 2003 Aug 30;362(9385):747
http://linkinghub.elsevier.com/retrieve/pii/S0140673603142171
HSL6413
Toop L, Richards D, Saunders B.
New Zealand deserves better. Direct-to-consumer advertising (DTCA) of prescription medicines in New Zealand: for health or for profit?
N Z Med J. 2003 Aug 22;116(1180):U556
HSL2101
Zachry WM 3rd, Dalen JE, Jackson TR.
Clinicians' responses to direct-to-consumer advertising of prescription medications.
Arch Intern Med 2003 Aug 11-25;163(15):1808-12
http://archinte.ama-assn.org/cgi/content/full/163/15/1808
HSL1385
Viale PH.
What nurse practitioners should know about direct-to-consumer advertising of prescription medications.
J Am Acad Nurse Pract 2003 Jul;15(7):297-304
HSL1429
Hollon MF, Larson EB, Koepsell TD, Downer AE.
Direct-to-consumer marketing of osteoporosis drugs and bone densitometry.
Ann Pharmacother 2003 Jul-Aug;37(7-8):976-81
http://www.theannals.com/cgi/content/full/37/7/976
HSL2224
Shani S.
[E-commerce of pharmaceuticals]
Harefuah. 2003 May 01;142(5):372-6, 397, 396
HSL6414
Toop L, Richards D, Dowell T.
The leadership role of general practice in public health: advocating a ban of direct-to-consumer advertising of prescription drugs in New Zealand.'Possums in the headlights?'.
Br J Gen Pract. 2003 Apr 1;53(489):342-5
HSL1479
Allison-Ottey S, Ruffin K, Allison K, Ottey CC.
Assessing the impact of direct-to-consumer advertisements on the AA patient: a multisite survey of patients during the office visit.
J Natl Med Assoc 2003 Feb;95(2):120-31
HSL1382
Vogel RJ, Ramachandran S, Zachry WM.
A 3-stage model for assessing the probable economic effects of direct-to-consumer advertising of pharmaceuticals.
Clin Ther 2003 Jan;25(1):309-29
HSL1438
Gahart MT, Duhamel LM, Dievler A, Price R.
Examining the FDA's oversight of direct-to-consumer advertising.
Health Aff (Millwood) 2003 Jan-Jun;Suppl
http://content.healthaffairs.org/cgi/reprint/hlthaff.w3.120v1
HSL1461
Calfee JE.
What do we know about direct-to-consumer advertising of prescription drugs?
Health Aff (Millwood) 2003 Jan-Jun;Suppl
http://content.healthaffairs.org/cgi/reprint/hlthaff.w3.116v1
HSL1468
Bodenheimer T.
Two advertisements for TV drug ads.
Health Aff (Millwood) 2003 Jan-Jun;Suppl
http://content.healthaffairs.org/cgi/reprint/hlthaff.w3.112v1
HSL1476
Avorn J.
Advertising and prescription drugs: promotion, education, and the public's health.
Health Aff (Millwood) 2003 Jan-Jun;Suppl
http://content.healthaffairs.org/cgi/reprint/hlthaff.w3.104v1
HSL2104
Weissman JS, Blumenthal D, Silk AJ, Zapert K, Newman M, Leitman R.
Consumers' reports on the health effects of direct-to-consumer drug advertising.
Health Aff (Millwood) 2003 Jan-Jun;Suppl
http://content.healthaffairs.org/cgi/reprint/hlthaff.w3.82v1
HSL2108
Vogel RJ, Ramachandran S, Zachry WM.
A 3-stage model for assessing the probable economic effects of direct-to-consumer advertising of pharmaceuticals.
Clin Ther 2003 Jan;25(1):309-29
Link to source with long URL
HSL2618
Klausner JD, Kim A, Kent C.
Are HIV drug advertisements contributing to increases in risk behavior among men in San Francisco, 2001?
AIDS 2002 Nov 22;16(17):2349-50
Link to source with long URL
HSL2871
Glasgow C, Schommer JC, Gupta K, Pierson K.
Promotion of prescription drugs to consumers: case study results.
J Manag Care Pharm 2002 Nov-Dec;8(6):512-8
Link to source with long URL
HSL2683
Cassels A.
Consumer drug advertising leads to MD backlash in Holland.
CMAJ 2002 Oct 1;167(7):793
http://www.cmaj.ca/cgi/content/full/167/7/793
HSL2858
Health ACTION.
European Parliament soundly rejects move towards direct-to-consumer advertising. HAI Europe applauds Parliament's decision to protect public health, not industry's interests
2002 Aug 24
http://www.haiweb.org/campaign/DTCA/pressreleaseEUrejectsDTCA.html
HSL2684
Sheldon T.
Dutch GPs call for ban on Novartis products.
BMJ 2002 Aug 17;325(7360):355
http://bmj.bmjjournals.com/cgi/content/full/325/7360/355
HSL2298
Pinkus RL.
From Lydia Pinkham to Bob Dole: what the changing face of direct-to-consumer drug advertising reveals about the professionalism of medicine.
Kennedy Inst Ethics J 2002 Jun;12(2):141-58
Link to source with long URL
HSL4163
Lasser KE, Allen PD, Woolhandler SJ, Himmelstein DU, Wolfe SM, Bor DH.
Timing of new black box warnings and withdrawals for prescription medications.
JAMA 2002 May 1;287(17):2215-20
http://jama.ama-assn.org/cgi/content/full/287/17/2215
HSL2373
Mintzes B.
For and against: Direct to consumer advertising is medicalising normal human experience: For.
BMJ 2002 Apr 13;324(7342):908-9
http://bmj.bmjjournals.com/cgi/content/full/324/7342/908
HSL2898
Bonaccorso S, Sturchio J.
Direct to consumer advertising is medicalising normal human experience: Against
BMJ 2002 Apr 13;324(7342):910-911
http://bmj.com/cgi/content/full/324/7342/910
HSL2875
The Editor
Just how tainted has medicine become.
Lancet 2002 April 6;359(9313):1167
http://linkinghub.elsevier.com/retrieve/pii/S0140673602081989
HSL2893
Cassels A.
Push for consumer drug ads gets cool reception in Europe.
CMAJ 2002 Apr 2;166(7):946
http://www.cmaj.ca/cgi/pmidlookup?view=long&pmid=11949998
HSL6415
Toop L, Richards D.
DTCA in New Zealand: the challenge of finding an acceptable balance
Br J Gen Pract. 2002 Apr 1;52(477):341
HSL2249
Viale PH.
Direct-to-consumer advertising of prescription medications: implications for patients with cancer.
Oncol Nurs Forum 2002 Apr;29(3):505-13
Link to source with long URL
HSL2614
Kunst H, Khan KS.
Quality of web-based medical information on stable COPD: comparison of non-commercial and commercial websites.
Health Info Libr J 2002 Mar;19(1):42-8
http://www.blackwell-synergy.com/doi/abs/10.1046/j.0265-6647.2001.00363.x
HSL1484
Wolfe SM.
Direct-to-consumer advertising--education or emotion promotion?
N Engl J Med 2002 Feb 14;346(7):524-6
http://content.nejm.org/cgi/content/extract/346/7/524
HSL2862
Holmer AF.
Direct-to-consumer advertising--strengthening our health care system.
N Engl J Med 2002 Feb 14;346(7):526-8
http://content.nejm.org/cgi/content/extract/346/7/526
HSL2878
Drazen JM.
The consumer and the learned intermediary in health care.
N Engl J Med 2002 Feb 14;346(7):523-4
http://content.nejm.org/cgi/content/full/346/7/523
HSL2868
Haugh R, Thrall TH, Scalise D.
Prescription for concern.
Hosp Health Netw 2002 Feb;76(2):44-9
Link to source with long URL
HSL1483
Zachry WM 3rd, Shepherd MD, Hinich MJ, Wilson JP, Brown CM, Lawson KA.
Relationship between direct-to-consumer advertising and physician diagnosing and prescribing.
Am J Health Syst Pharm 2002 Jan 1;59(1):42-9
http://www.ajhp.org/cgi/reprint/59/1/42
HSL2259
Sumpradit N, Fors SW, McCormick L.
Consumers' attitudes and behavior toward prescription drug advertising.
Am J Health Behav 2002 Jan-Feb;26(1):68-75
Link to source with long URL
HSL2308
National Health Council 2002 Jan
www.nationalhealthcouncil.org/advocacy/DTC_paper.pdf
HSL112
Rosenthal MB, Berndt ER, Donohue JM, Frank RG, Epstein AM.
Promotion of prescription drugs to consumers
N Engl J Med 2002;346:498-505
http://content.nejm.org/cgi/content/abstract/346/7/498
HSL113
Mintzes B, Barer ML, Kravitz RL, Kazanjian A, Bassett K, Lexchin J, et al.
Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey
BMJ 2002;324:278-279
http://bmj.bmjjournals.com/cgi/content/full/324/7332/278
HSL2569
Lyles A.
Direct marketing of pharmaceuticals to consumers.
Annu Rev Public Health 2002;23:73-91
Link to source with long URL
HSL2611
Lefebvre T.
[Archeology of the radio pharmaceutical advertisement].
Rev Hist Pharm (Paris). 2002;50(336):647-64
Link to source with long URL
HSL2376
Menon AM, Deshpande AD, Perri M 3rd, Zinkhan GM.
Trust in online prescription drug information among internet users: the impact on information search behavior after exposure to direct-to-consumer advertising.
Health Mark Q 2002;20(1):17-35
Link to source with long URL
HSL2622
Kemper DW, Mettler M.
A consumer-empowered response to direct-to-consumer advertising of prescription drugs.
Manag Care Q 2002 Spring;10(2):52-4
Link to source with long URL
HSL2857
Health Action International.
The Erice Statement on drug advertising to consumers
2002
http://www.haiweb.org/campaign/DTCA/EriceStatement2002.doc
HSL2864
Hochhauser M.
Which prescription for the illegible and unreadable DTC (direct-to-consumer) brief summary--major surgery or euthanasia?
Manag Care Q 2002 Sum;10(3):6-10
Link to source with long URL
HSL2874
Findlay S.
Do ads really drive pharmaceutical sales? The true effects of DTC advertising remain a mystery
Mark Health Serv. 2002 Spr;22(1):20-25
HSL2895
Calfee JE.
The role of marketing in pharmaceutical research and development.
Pharmacoeconomics 2002;20
Link to source with long URL
HSL4165
Coney S.
Direct-to-consumer advertising of prescription pharmaceuticals: a consumer perspective from New Zealand.
J Public Policy Market. 2002;21:213–223.
HSL2775
Anonymous .
DTC advertising: Mixed messages
CMJ 2001 Dec;133(10):20
HSL2630
Meek C .
Direct-to-consumer advertising of prescription medicines: A review of international policy and evidence
Royal Pharmaceutical Society of Great Britain 2001 Nov
http://www.rpsgb.org.uk/pdfs/dtcarep.pdf
HSL2633
Brodie M.
Understanding the effects of direct-to-consumer prescription drug advertising
: Henry J. Kaiser Family Foundation; 2001 Nov
HSL2961
Meek C.
2001 Nov
http://www.rpsgb.org.uk/pdfs/dtcarep.pdf
HSL2669
Silversides A.
Direct-to-consumer prescription drug ads getting bolder.
CMAJ 2001 Aug 21;165(4):462
http://www.cmaj.ca/cgi/content/full/165/4/462
HSL2955
Morgan S.
2001 Aug
www.chspr.ubc.ca//hpru/pdf/dtca-v5-econ.pdf
HSL2958
Mintzes , B BARER, Bassett K, Kazanjian A, Evans R.
Untitled
2001 Aug
www.chspr.ubc.ca//hpru/pdf/dtca-v3-compsurvey.pdf
HSL2960
Mintzes B.
2001 Aug
www.chspr.ubc.ca//hpru/pdf/dtca-v2-litreview.pdf
HSL2957
Mintzes B, Kazanjian , Bassett K, Lexchin J.
Untitled
2001 Jun
www.chspr.ubc.ca//hpru/pdf/dtca-v4-expertsurvey.pdf
HSL121
Stout E.
Doctoring sales
Sales & Marketing Management 2001 May:52-60
Nil
HSL2755
Belkin , L .
Prime time pushers
2001 Mar:31-37
http://motherjones.com/magazine/MA01/drug.html
HSL2367
Noonan D.
GM's War on Drug Costs.
Newsweek 2001 Feb 26:46
HSL2753
GM's war on drugs
Newsweek 2001 Feb 26:46-48
HSL2741
Lal A.
Pharmaceutical drug promotion: how it is being practiced in India?
J Assoc Physicians India 2001 Feb;49:266-73
HSL2740
Therapeutic Products Programme.
Advertising Standards Canada and the Therapeutic Product Programme's roles and consultation related to advertising review and complaint adjudication
2001 Jan 22
Link to source with long URL
HSL126
Lill DJ, Peterson RT.
Older adult portrayal in television commercials by pharmaceutical manufacturers: an analysis
Journal of Pharmaceutical Marketing & Management 2001;14(1):81-96
Nil
HSL131
Findlay SD.
Direct-to-consumer promotion of prescription drugs: economic implications for patients, payers and providers
Pharmacoeconomics 2001;19(2):109-199
Nil
HSL2736
Eichner , R MAROONICK, T J.
A review of direct-to-consumer (DTC) advertising and sales of prescription drugs: does DTC advertising increase sales and market share?
Journal of Pharmaceutical Marketing & Management 2001;13(4):19-42
HSL2737
Mintzes B, Baraldi R .
Direct-to-consumer prescription drug advertising: when public health is no longer a priority
DES Action Canada 2001
HSL2738
Rubin , Ph .
Pharmaceutical advertising as a consumer empowerment device
Journal of Biolaw & Business 2001;4(4):59-65
HSL2959
Mintzes B, Baraldi R.
Direct to Consumer Prescription Drug Advertising: When preventing harm is no longer a priority
: DES Action Canada; 2001
http://www.web.net/~desact/anglais/anglais.html
HSL2962
Meek C.
2001
www.rpsgb.org.uk/pdfs/dtcarep.pdf
HSL359
Bell RA, Wilkes MS, Kravitz RL.
The educational value of consumer-targeted prescription drug print advertising.
J Fam Pract 2000 Dec;49(12):1092-8
Nil
HSL8529
Pines WL.
Direct-to-consumer advertising.
Ann Pharmacother 2000 Nov;34(11):1341-4
http://www.theannals.com/cgi/reprint/34/11/1341
HSL3040
Mintzes B, Lippman A.
Re: Selling, or selling out? [response]
Journal of the Society of Obstetricians and Gynaecologists of Canada 2000 Oct;22(10):786-787
HSL8516
Aitken M, Holt F.
Consumer choice or chaos?
Chemist and Druggist 2000 Jun 10;253:34, 36
HSL4169
Bell RA, Kravitz RL, Wilkes MS.
Direct-to-consumer prescription drug advertising, 1989-1998. A content analysis of conditions, targets, inducements, and appeals.
J Fam Pract 2000 Apr;49(4):329-35
http://www.jfponline.com/Pages.asp?AID=2488
HSL2985
Wilkes M.
Direct-to-consumer prescription drug advertising: trends, impact, and implications
Health Affairs 2000;19(2):110-128
HSL5859
Bell RA, Kravitz RL, Wilkes MS.
Direct-to-consumer prescription drug advertising and the public.
J Gen Intern Med 1999 Nov 01;14(11):651-7
http://www.blackwell-synergy.com/doi/abs/10.1046/j.1525-1497.1999.01049.x
HSL2632
Perri M 3rd, Shinde S, Banavali R.
The past, present, and future of direct-to-consumer prescription drug advertising.
Clin Ther 2001 nov;21(10):1798-811
Link to source with long URL
HSL4147
Dyer C.
Incontinence campaign tests limits of advertising rules.
BMJ 1999 Sep 4;319(7210):591
http://bmj.bmjjournals.com/cgi/content/full/319/7210/591
HSL2410
Bell RA, Wilkes MS, Kravitz RL.
Advertisement-induced prescription drug requests: patients' anticipated reactions to a physician who refuses.
J Fam Pract 1999 Jun;48(6):446-52
HSL4143
Holmer AF.
Direct-to-consumer prescription drug advertising builds bridges between patients and physicians.
JAMA 1999 Jan 27;281(4):380-2
http://jama.ama-assn.org/cgi/content/full/281/4/380
HSL5516
McGhan WF.
Employer and consumer perspectives.
Value Health 1998 Nov 01;1(4):237-42
http://www.blackwell-synergy.com/doi/abs/10.1046/j.1524-4733.1998.140237.x
HSL535
Levin AA.
Advertising prescription-only drugs.
Lancet 1998 May 23;351(9115):1583
Nil
HSL529
Medawar C.
Advertising prescription-only drugs.
Lancet 1998 May 23;351(9115):1584
Link to source with long URL
HSL526
Nightingale SL.
Advertising prescription-only drugs.
Lancet 1998 May 23;351(9115):1582
http://linkinghub.elsevier.com/retrieve/pii/S0140673698260211
HSL543
Inlander CB.
Advertising prescription-only drugs.
Lancet 1998 May 23;351(9115):1583
Link to source with long URL
HSL546
Goldstein MR.
Advertising prescription-only drugs.
Lancet 1998 May 23;351(9115):1583-4
Link to source with long URL
HSL553
Brown P.
Advertising prescription-only drugs.
Lancet 1998 May 23;351(9115):1582-3
http://linkinghub.elsevier.com/retrieve/pii/S0140673698260211
HSL516
Schommer JC, Doucette WR, Mehta BH.
Rote learning after exposure to a direct-to-consumer television advertisement for a prescription drug.
Clin Ther 1998 May-Jun;20(3):617-32
Link to source with long URL
HSL503
Pushing ethical pharmaceuticals direct to the public.
Lancet 1998 3 28;351(9107):921
Nil
HSL558
Hoen E.
Direct-to-consumer advertising: for better profits or for better health?
Am J Health Syst Pharm 1998 Mar 15;55(6):594-7
http://www.ajhp.org/cgi/reprint/55/6/594.pdf
HSL520
Reeves KN.
Direct-to-consumer broadcast advertising: empowering the consumer or manipulating a vulnerable population?
Food Drug Law J 1998;53(4):661-79
Nil
HSL524
Parker BJ, Delene LM.
Direct-to-consumer prescription drug advertising: content analyis and public policy implications
Journal of Pharmaceutical Marketing & Management 1998;12(4):27
Nil
HSL4167
Brown P.
Will DTC advertising shape the future of the industry?
Scrip Mag. 1998:3-4
HSL704
Lipsky MS, Taylor CA.
The opinions and experiences of family physicians regarding direct-to-consumer advertising.
J Fam Pract 1997 Dec;45(6):495-9
HSL4145
FDA proposes new guidance on direct-to-consumer ads.
Scrip. 1997 Aug 15;2258:12
HSL695
McElwain M.
Recent progress in drug advertising.
Can Fam Physician 1997 Jun;43:1041-2
Nil
HSL735
Bradley LR, Zito JM.
Direct-to-consumer prescription drug advertising.
Med Care 1997 Jan;35(1):86-9
HSL702
Maddox LM, Katsanis LP.
Direct-to-consumer advertising of prescription drugs in Canada: its potential effect on patient-physician interaction.
Journal of Pharmaceutical Marketing & Management 1997;12(1):1-21
HSL703
MacKowiak ED, O'Connor TW, Geller H, Nguyen J, Wilkes W.
A survey of pharmacists' and pharmacy students' attitudes toward OTC advertising
Journal of Pharmaceutical Marketing & Management 1997;12(1):33-49
HSL706
Lexchin J.
Recent progress in drug advertising
Can Fam Physician 1997;43:1041-1042
HSL754
Sullivan P.
CMA calls for controls on prescription-drug advertising aimed at patients
Can Med Assoc J 1996;154:1889-1990
HSL763
Roth MS.
Patterns in direct-to-consumer prescription drug print advertising and their public policy implications.
Journal of Public Policy & Marketing 1996;15(1):63-75
HSL771
McLaren S.
Cause and effect: prescription drug advertising goes under the microscope
Can Pharm JCan Pharm JCan Pharm J 1996;129(5):26-30
HSL774
Lexchin J.
Direct to consumer advertising of prescription drugs: the next steps
Can J Clin Pharmacol 1996;3(2):65
HSL779
Kopp SW.
Direct-to-consumer advertising and consumer prescription prices
Drug Information Journal 1996;30:59-65
HSL807
Amonkar MM, Lively BT.
Pharmacists' attitudes toward product-specific television advertising of prescription drugs
J Pharm Mark Manage 1996;11(2):3-20
HSL825
Reinstein JA.
OTC advertising: in whose interest? The manufacturer’s viewpoint
WHO Drug Information 1995;9(1):11-13
HSL829
Petroshius SM, Titus PA, Hatch KJ.
Physician attitudes toward pharmaceutical advertising
J Advert Res 1995;35(6):41-51
HSL1707
Chetley A.
OTC advertising: in whose interest? A consumer’s viewpoint
WHO Drug Information 1995;9(1):10-11
HSL6276
Basar L.
Practical considerations when evaluating direct-to-consumer advertising as a marketing strategy for prescription medications
Drug Information Journal 1994;28:461-470
HSL6465
Coney S.
NZ review of drug prescribing and advertising
Lancet 1994;344:1353-1354
HSL5697
Lober CW.
Ethics in pharmaceutical advertising.
Dermatol Clin 1993 Apr 01;11(2):285-8
HSL5782
Penick TM.
New trends in direct-to-consumer advertising: The Actigall campaign
Journal of Pharmaceutical Marketing & Management 1993;7(3):95-107
HSL5155
Alperstein N, Peyrot M
Consumer awareness of prescription drug advertising
Journal of Advertising Research 1993;33(4):50-56
HSL5144
Dower , Moira .
DTC ads for Europe?
Scrip Mag 1992-1993 Dec-Jan(10):10
HSL5140
Ukens C.
Consumer advertising found to pack prescribing punch
Drug Topics 1992 Nov 9;136(21):24, 26
HSL5132
Re: the promotion of aspirin
1992 Nov 1
HSL5138
Spiro HM.
Speaking out: A physician looks at direct-to-consumer advertising
Medical Marketing & Media 1992 Nov 1;27(11):24, 26, 28
HSL4945
Broach M.
Direct-to-consumer advertising with added inducements [1st of 2 replies]
JAMA 1992 Jan 22-29;267(4):508
HSL4947
Morris LA, Graham CF.
Direct-to-consumer advertising with added inducements [2nd of 2 replies]
JAMA 1992 Jan 22-29;267(4):508
HSL4789
Basara LR.
Direct-to-consumer advertising: today’s issues and tomorrow’s outlook
Journal of Drug Issues 1992;22:317-330
HSL4796
Bleidt B.
Marketing activities: the keystone of capitalism—increasing the availability of prescription drugs through pharmaceutical promotion
Journal of Drug Issues 1992;22:277-293
HSL4810
Cope JD.
Nonprescription drugs and the regulation of advertising
Journal of Drug Issues 1992;22:257-264
HSL4813
Data JL, Barton KS.
Advertising baldly to the public
New England Journal of Medicine 1992;326:330-331
HSL4836
Ingram RA.
Some comments on direct-to-consumer advertising
Journal of Pharmaceutical Marketing & Management 1992;7(1):67-74
HSL4856
McGregor A.
Pharmaceutical industry to be taken to task
Lancet 1992;339:1103-1104
HSL4897
Rogers A.
EC pharmaceutical directives
Lancet 1992;339:483
HSL4924
Waldholz MR.
Prescription drug advertising: A critic's perspective
Journal of Pharmaceutical Marketing & Management 1992;7(1):43-52
HSL4927
Watts MR, Wilkenfeld JD.
The role of the Federal Trade Commission in regulating non-prescription drug advertising and promotion
Journal of Drug Issues 1992;22:265-276
HSL4738
Everett SE.
Lay audience response to prescription drug advertising
Journal of Advertising Research 1991 Apr-May;31:43-49
HSL4652
Cutrer CM, Pleil AM.
Potential outcomes associated with direct-to-consumer advertising of prescription drugs: physicians’ perspectives
Journal of Pharmaceutical Marketing & Management 1991;5(3-19)
HSL4658
Gilgore LS.
A consideration of direct-to-consumer advertising of prescription drugs and potential legal problems with the brief summary requirement: Is the FDA's regulatory authority illusory?
Food Drug Cosmetic Law Journal 1991;46:849-859
HSL4702
Ruby LA, Montagne M.
Direct-to-consumer advertising: a case study of the Rogaine® campaign
Journal of Pharmaceutical Marketing & Management 1991;6(2):21-32
HSL4706
Sibbison JB.
Prescription drug advertising to the public
Lancet 1991;337:724
HSL4621
As advertised on TV
Economist 1990 Jun 9:68
HSL4610
Direct-to-consumer advertising becoming more accepted
Medical Marketing & Media 1990 Mar;25(3):64
HSL4498
Consumer information
Lancet 1990(335):1395
HSL4508
Berube B.
Marketing ibuprofen
Canadian Pharmaceutical Journal 1990;123:402
HSL4509
Berube B.
The slick sell: the pharmacist’s view
Canadian Pharmaceutical Journal 1990;123:400-401
HSL4510
Berube B.
The subtle sell: an overview
Canadian Pharmaceutical Journal 1990;123:397-398
HSL4521
Chetley A.
A healthy business? World health and the pharmaceutical industry
Zed Books 1990
Link to source with long URL
HSL4555
Morris LA, Banks DB.
New issues in drug advertising and labeling: the five advertising end-runs
Drug Information Journal 1990;24:639-646
HSL4593
Information or communication? A consumer study of television advertising
Taylor Nelson Research 1990
HSL4620
Hamer P.
More medication for healthy women!
DES Action Canada Newsletter 1990(23):1-2
www.web.net/~desact
HSL4478
Miller A, Barrett T, Bradburn E.
Pitching to patients
1989 May 8:40-41
HSL4470
Vreeland LN.
The selling of Retin-A
Money 1989 Apr:75-80, 84, 87
HSL4444
Morris LA, Mazis MB, Brinberg D.
Risk disclosures in televised prescription drug advertising to consumers
Journal of Public Policy & Marketing 1989;8:64-80
HSL4109
Direct-to-consumer advertising debated; APhA endorses some forms
American Pharmacy 1988 Nov;28(11):10-11
HSL4091
Kaplar RT.
It's time to remove the brief summary from DTC print ads
Medical Marketing & Media 1988 May;33(5):44-46, 48
HSL4023
Miles S.
Searle's "Patient Promise".
N Engl J Med 1988 Mar 24;318(12):790
HSL3994
Cohen EP.
Direct-to-the-public advertisement of prescription drugs.
N Engl J Med 1988 Feb 11;318(6):373-6
HSL3993
Cohen EP.
Advertising of prescription drugs
New England Journal of Medicine 1988;319:314-315
HSL4020
Masson A, Rubin PH.
Advertising of prescription drugs
New England Journal of Medicine 1988;319:314
HSL4030
Pearse WH.
Advertising of prescription drugs
New England Journal of Medicine 1988;319:314
HSL4072
Tan M.
Dying for drugs: pill power and politics in the Philippines
1988
HSL3970
DOH proposes regulating of drug ads
Drug Monitor 1987 Aug;2(8):3-5
HSL3961
Perri M, Nelson AA Jr.
An exploratory analysis of consumer recognition of direct-to-consumer advertising of prescription medications.
J Health Care Mark 1987 Mar;7(1):9-17
HSL3892
Johnstone JM.
Special problems in direct-to-consumer advertising of prescription drugs
Food Drug Cosmetic Law Journal 1987;42:315-322
HSL3909
Perri M, Dickson WM.
Direct to consumer prescription drug advertising: consumer attitudes and physician reaction
Journal of Pharmaceutical Marketing & Management 1987;2(1):3-25
HSL3976
Tucker GK, Smith MC.
Direct-to-consumer advertising: Effects of different formats of warning information disclosure on cognitive reactions of adults
Journal of Pharmaceutical Marketing & Management 1987;2(1):27-41
HSL3842
Shugar GS.
Mixed opinions on direct-to-consumer advertising
Medical Marketing & Media 1986 Aug;21(8):36-38, 40-41
HSL3840
Pierpaoli PG.
ASHP's position on direct-to-consumer advertising of prescription drug products.
Am J Hosp Pharm 1986 Jul;43(7):1763-5
HSL3836
To what extent should pharmaceutical houses advertise to the public?
Pharmacy Times 1986 Mar;52(3):86-88, 90, 93
HSL3811
Morris LA, Brinberg D, Klimberg R, Rivera C, Millstein LG.
The attitudes of consumers toward direct advertising of prescription drugs.
Public Health Rep 1986 Jan-Feb;101(1):82-9
HSL3833
How physicians feel about Rx drug product ads beamed at the public
Pharmacy Times 1986 Jan;52(1):85-88, 91-92
HSL3762
Bader M.
Advertising prescription drugs to the public
New England Journal of Medicine 1986;314:523
HSL3774
Collins GL.
Prescription drug advertising: a medical view
Journal of Pharmaceutical Marketing & Management 1986;1(2):19-22
HSL3779
Dingell JD.
Advertising prescription drugs to the public
New England Journal of Medicine 1986;314:524
HSL3781
Feather KR.
Direct to the consumer advertising—how close can we come?
Journal of Pharmaceutical Marketing & Management 1986;1(2):67-71
HSL3785
Henderson AM.
The CBS consumer model
Journal of Pharmaceutical Marketing & Management 1986;1(2):7-11
HSL3787
Kerr HD, Brobny EC.
Advertising prescription drugs to the public
New England Journal of Medicine 1986;314:523-524
HSL3798
Lavizzo-mourey R.
Medications and the elderly
Journal of Pharmaceutical Marketing & Management 1986;1(2):45-50
HSL3801
Lipton C.
Consumer advertising and pharmaceuticals: a happy marriage?
Journal of Pharmaceutical Marketing & Management 1986;1(2):23-28
HSL3805
Masson A, Rubin PH.
Advertising prescription drugs to the public
New England Journal of Medicine 1986;314:524
HSL3806
Masson A, Rubin PH.
Warning: brief summaries may be hazardous to your health (and wealth) or the real issues in prescription drug advertising to consumers
Journal of Pharmaceutical Marketing & Management 1986;1(2):29-43
HSL3809
McMahon FG.
Advertising prescription drugs to the public
New England Journal of Medicine 1986;314:524
HSL3810
Moench EA.
The Boots advertising campaign
Journal of Pharmaceutical Marketing & Management 1986;1(2):51-55
HSL3815
O’brien M.
Advertising prescription drugs to the public
New England Journal of Medicine 1986;314:523
HSL3817
Rockwell T.
The Lifetime experience with prescription drug advertising exposed to consumers
Journal of Pharmaceutical Marketing & Management 1986;1(2):13-18
HSL3820
Schueler KR.
Direct-to-consumer promotion
Journal of Pharmaceutical Marketing & Management 1986;1(2):57-65
HSL3829
Vener AM, Krupka LR.
Over-the-counter drug advertising in gender oriented popular magazines.
J Drug Educ 1986;16(4):367-81
HSL3751
FDA withdraws moratorium on direct-to-consumer advertising
American Pharmacy 1985 Nov 01;25(11):9-11
HSL3718
Krupka LR, Vener AM.
Prescription drug advertising: trends and implications.
Soc Sci Med 1985;20(3):191-7
HSL3725
Masson A, Rubin PH.
Matching prescription drugs and consumers: The benefits of direct advertising.
New England Journal of Medicine 1985;313:513-515
HSL3676
Mastroni N.
The industry is tuning out on direct-to-consumer advertising.
Med Mark Media 1984 Jul;19(7):10-1,
HSL3679
Liebman M.
Prescription drug advertising to the general public.
Hosp Pract (Off Ed) 1984 May;19(5):13,
HSL3674
Physicians, pharmacists, and consumers react to a direct-to-consumer campaign
Medical Marketing & Media 1984 Apr 01;19(4):24, 26
HSL3672
Urbanski A.
Drug marketers write an Rx for consumers
Sales & Marketing Management 1984 Mar 12;132:74-75, 78
HSL3670
Murphy DH.
Direct to consumer advertising of prescription drugs. FDA's first round of tests
Am Pharm. 1984 Feb 01;24(2):20-3
HSL3665
Survey: Consumers don't favor prescription drug advertising
American Pharmacy 1984 Jan 01;24(1):10
HSL3635
Hoff LC.
Advertising prescription drugs direct to the public: What are the issues?
Vitsl Speeches of the Day 1984;50:573-576
HSL3646
Morris LA, Millstein LG.
Drug advertising to consumers: effects of formats for magazine and television advertisements
Food Drug Cosmetic Law Journal 1984;39:497-503
HSL3647
Novitch M.
Direct-to-consumer advertising of prescription drugs
Food Drug Cosmetic Law Journal 1984;39:306-311
HSL3655
Schapiro R.
Rx: consumer ads. Promoting prescription drugs to the consumer
New Physician 1984;33(4):8-11
HSL3605
Millstein LG.
The regulation of prescription drug advertising.
Am Pharm 1983 Sep;NS23(9):54-7
HSL3601
Kolata G.
Prescription drug ads put FDA on the spot.
Science 1983 Apr 22;220(4595):387-8
HSL3600
Truth in drug advertising
Dispatch 1983(25):1-5
HSL3564
Kushner D.
Two-thirds of RPh's & MD's object to makers' promotion of Rx drugs to the public
American Druggist 1982 Oct;186(1):14, 16, 21-22
HSL3549
O'Brien WM.
Alleged direct promotion of prescription drugs to consumers.
N Engl J Med 1982 Jan 21;306(3):181-2
HSL3546
Melrose D.
Bitter pills: medicines and the Third World poor
1982
HSL3132
Buc N.
Current regulatory issues in marketing prescription drugs: Comparative claims and advertising to consumers
Food Drug Cosmetic Law Journal 1982;37:402-408
HSL3539
Defesche CL.
Alleged direct promotion of prescription drugs to consumers
New England Journal of Medicine 1982;306:182
HSL3543
Lanier B.
Drug company advertising to the public
JAMA 1982;248:1163
HSL3551
Rheinstein PH.
A head start, a broader audience, and an emphasis on difference: The new frontiers of prescription drug promotion
Food Drug Cosmetic Law Journal 1982;37:330-335
HSL3443
Solomon SD, Grimmett BL, Maurer KH, Levin NW.
Complaint about promotion of new anti-arthritic drug.
N Engl J Med 1979 Jan 25;300(4):203
HSL3326
Day RL.
…Up to Eight Hours of Relief… Dissecting and analysing an o-t-c drug advertisement
Journal of the American Pharmaceutical Association 1976 September 01;16(9):496-499, 504
HSL3324
Berlow L.
The pharmacist and television advertising.
J Am Pharm Assoc 1976 Sep;16(9):510-2
HSL3325
Cope JD.
The charges against O-T-C medicine advertising--are they deserved?
J Am Pharm Assoc 1976 Sep;16(9):500-4
HSL3327
Griffenhagen G.
Can O-T-C advertising ever be justified?
Journal of the American Pharmaceutical Association 1976 Sep;16(9):495
HSL3328
Helffrich S.
The broadcaster view O-T-C advertising.
J Am Pharm Assoc 1976 Sep;16(9):507-9,
HSL3329
Hodes B.
Are magazine ads for O-T-C drugs based on fact?
J Am Pharm Assoc 1976 Sep;16(9):513-5
HSL3330
Rheinstein PH, Mazis MB.
Regulation of O-T-C drug advertising: the FDA "prescription".
J Am Pharm Assoc 1976 Sep;16(9):505-6,
HSL3314
Petersen B, Kuriansky JB, Konheim CS, Anderson RS, Tesar J, Podell RN, Ho A, Cowan NM.
Television advertising and drug use
American Journal of Public Health 1976;66(10):975-978
HSL3332
Choate R, Debevoise N.
Caution! Keep this commercial out of reach of children!
Journal of Drug Issues 1976;6(1):91-98
HSL3333
Cope JD.
Television advertising of nonprescription medicines: The case for the defendant
Journal of Drug Issues 1976;6(1):85-90
HSL3334
Donegan TJ.
The role of the Federal Trade Commission in regulating drug advertising: 1975 perspective
Journal of Drug Issues 1976;6(1):99-104
HSL3336
Jensen GF, Christiansen RL.
Drug advertising should be banned: Utah's approach
Journal of Drug Issues 1976;6(1):65-71
HSL3337
Kuriansky JB.
TV advertising and abuse of over-the-counter drugs
Journal of Drug Issues 1976;6(1):79-84
HSL3259
Braren W.
Deception in advertising and the failure of self-regulation
Journal of Drug Issues 1974;4:213-216
HSL3261
Johnson N.
Junkie television
Journal of Drug Issues 1974;4:227-231
HSL3262
Kanter DL.
Research on the effects of over-the-counter drug advertising
Journal of Drug Issues 1974;4:223-226
HSL3264
Penna RD.
American Pharmaceutical Association
Journal of Drug Issues 1974;4:268-273
HSL3095
Canadian Association of Retired Persons
C.A.R.P.’s position on the direct-to-consumer advertising of prescription drugs
Canadian Association of Retired Persons
www.hc-sc.gc.ca/hpb-dgps/therapeut/zfiles/english/consult/wkshd2ca.zip